The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study
- PMID: 15936235
- DOI: 10.1016/j.ymgme.2005.04.008
The activity of wild-type and mutant phenylalanine hydroxylase and its regulation by phenylalanine and tetrahydrobiopterin at physiological and pathological concentrations: an isothermal titration calorimetry study
Abstract
The activity of phenylalanine hydroxylase (PAH) is regulated by the levels of both the substrate (L-Phe) and the natural cofactor (6R)-tetrahydrobiopterin (BH4). It has recently been observed that many PAH mutants associated with BH4-responsive phenylketonuria display abnormal kinetic and regulatory properties as shown by standard kinetic analyses. In this work, we have developed a high-sensitive and high-throughput activity assay based on isothermal titration calorimetry (ITC) in order to study the kinetic properties of wild-type PAH (wt-PAH) and the BH4-responsive c.204A>T (p.R68S) mutant at physiological and superphysiological concentrations of L-Phe and BH4. Compared to wt-PAH, the p.R68S mutant showed reduced apparent and equilibrium binding affinity for the natural cofactor and increased affinity and non-cooperative response for L-Phe, together with a strong substrate inhibition that is alleviated at high BH4 concentrations. For both wt-PAH and mutant, the apparent affinity for BH4 decreases at increasing L-Phe concentrations, and the affinity for the substrate also depends on the cofactor concentration. Our results indicate that the activity landscape for wt and mutant enzymes is more complex than expected from standard kinetic analyses and highlight the applicability of this ITC-based assay to characterize the activity and regulation of PAH at a wide range of substrate and cofactor concentrations. Moreover, the results aid to understand the activity dynamics of wild-type and mutant PAH under physiological and pathological conditions, as well as BH4-responsiveness in certain PKU mutations.
Similar articles
-
Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations.Hum Mutat. 2004 Nov;24(5):388-99. doi: 10.1002/humu.20097. Hum Mutat. 2004. PMID: 15459954
-
Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.FEBS Lett. 2004 Nov 19;577(3):507-11. doi: 10.1016/j.febslet.2004.10.056. FEBS Lett. 2004. PMID: 15556637
-
Response of patients with phenylketonuria in the US to tetrahydrobiopterin.Mol Genet Metab. 2005 Dec;86 Suppl 1:S17-21. doi: 10.1016/j.ymgme.2005.06.024. Epub 2005 Sep 6. Mol Genet Metab. 2005. PMID: 16143554 Clinical Trial.
-
Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients.Mol Genet Metab. 2005 Dec;86 Suppl 1:S11-6. doi: 10.1016/j.ymgme.2005.06.009. Epub 2005 Aug 8. Mol Genet Metab. 2005. PMID: 16091306 Review.
-
A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.J Inherit Metab Dis. 2001 Apr;24(2):213-30. doi: 10.1023/a:1010371002631. J Inherit Metab Dis. 2001. PMID: 11405341 Review.
Cited by
-
Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice.Front Bioeng Biotechnol. 2022 Oct 7;10:993298. doi: 10.3389/fbioe.2022.993298. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36277393 Free PMC article.
-
Activation of phenylalanine hydroxylase induces positive cooperativity toward the natural cofactor.J Biol Chem. 2010 Oct 1;285(40):30686-97. doi: 10.1074/jbc.M110.124016. Epub 2010 Jul 27. J Biol Chem. 2010. PMID: 20667834 Free PMC article.
-
Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.Am J Hum Genet. 2007 Nov;81(5):1006-24. doi: 10.1086/521879. Epub 2007 Oct 2. Am J Hum Genet. 2007. PMID: 17924342 Free PMC article.
-
Pterin Profiling in Serum, Dried Blood Spot, and Urine Samples Using LC-MS/MS in Patients with Inherited Hyperphenylalaninemia.Mol Syndromol. 2024 Jun;15(3):185-193. doi: 10.1159/000535853. Epub 2024 Jan 15. Mol Syndromol. 2024. PMID: 38841329 Free PMC article.
-
Dietary intervention in the management of phenylketonuria: current perspectives.Pediatric Health Med Ther. 2016 Dec 1;7:155-163. doi: 10.2147/PHMT.S49329. eCollection 2016. Pediatric Health Med Ther. 2016. PMID: 29388626 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources